{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:34:43Z","timestamp":1793388883810,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.slasd.2024.100179","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T07:14:04Z","timestamp":1723619644000},"page":"100179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a sensitive high-throughput enzymatic assay capable of measuring sub-nanomolar inhibitors of SARS-CoV2 Mpro"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5748-5276","authenticated-orcid":false,"given":"Peter","family":"Kovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-8168","authenticated-orcid":false,"given":"Paul L","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Korepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo A","family":"Afanador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5176-2273","authenticated-orcid":false,"given":"Michael R","family":"Schrimpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa I","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-1811","authenticated-orcid":false,"given":"David A","family":"Degoey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha M","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2024.100179_bib0001","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.slasd.2024.100179_bib0002","first-page":"1041","article-title":"Covid-19: WHO declares end of global health emergency","volume":"381","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.slasd.2024.100179_bib0003","unstructured":"Covid-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at. Johns Hopkins University (JHU). ArcGIS. Johns Hopkins University. Mar 10, 2023."},{"issue":"9","key":"10.1016\/j.slasd.2024.100179_bib0004","first-page":"13","article-title":"Pandemics throughout the history","volume":"20","author":"Sampath","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.slasd.2024.100179_bib0005","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1038\/s41467-023-41879-2","article-title":"Long-term health impacts of COVID-19 among 242,712 adults in England","volume":"14","author":"Atchison","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.slasd.2024.100179_bib0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.slasd.2024.100179_bib0007","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.slasd.2024.100179_bib0008","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.slasd.2024.100179_bib0009","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for high-risk, non-hospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.slasd.2024.100179_bib0010","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.7326\/M23-2887","article-title":"Rebound of COVID-19 with Nirmatrelvir\u2013Ritonavir antiviral therapy","volume":"176","author":"Cohen","year":"2023","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.slasd.2024.100179_bib0011","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1074\/jbc.M310875200","article-title":"Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase","volume":"279","author":"Fan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2024.100179_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.slasd.2024.100179_bib0013","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.3390\/ijms21155346","article-title":"Computational studies of SARS-CoV-2 3CLpro: insights from MD simulations","volume":"21","author":"Grottesi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.slasd.2024.100179_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tibs.2004.09.006","volume":"29","author":"Marianayagam","year":"2004","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"10.1016\/j.slasd.2024.100179_bib0015","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1039\/C4MB00022F","article-title":"Dimerization-based control of cooperativity","volume":"10","author":"Bouhaddou","year":"2014","journal-title":"Mol Biosyst"},{"issue":"1","key":"10.1016\/j.slasd.2024.100179_bib0016","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BJ20120035","article-title":"Mechanism and specificity of the human paracaspase MALT1","volume":"443","author":"Hachmann","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.slasd.2024.100179_bib0017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01918191","article-title":"On the understanding of the effects of salts","volume":"24","author":"Hofmeister","year":"1888","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.slasd.2024.100179_bib0018","doi-asserted-by":"crossref","first-page":"30340","DOI":"10.1039\/C8CP06061D","article-title":"Ion-specificity and surface water dynamics in protein solutions","volume":"20","author":"Janc","year":"2018","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.slasd.2024.100179_bib0019","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.slasd.2024.100179_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ab.2007.06.020","article-title":"Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease","volume":"368","author":"Konstantinidis","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1016\/j.slasd.2024.100179_bib0021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbrc.2004.04.098","article-title":"Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate","volume":"318","author":"Kuo","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.slasd.2024.100179_bib0022","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","article-title":"SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging","volume":"17","author":"Rut","year":"2021","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.slasd.2024.100179_bib0023","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/abio.1998.3014","article-title":"Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction","volume":"267","author":"Liu","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.slasd.2024.100179_bib0024","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/s41467-021-23328-0","article-title":"Drug repurposing screens identify chemical entities for the development of COVID-19 interventions","volume":"12","author":"Bakowski","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2024.100179_bib0025","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/s41467-020-19662-4","article-title":"Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2024.100179_bib0026","doi-asserted-by":"crossref","first-page":"23544","DOI":"10.1002\/anie.202010316","article-title":"Allosteric inhibition of the SARS-CoV-2 main protease: insights from mass spectrometry based assays","volume":"59","author":"El-Baba","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.slasd.2024.100179_bib0027","doi-asserted-by":"crossref","first-page":"9283","DOI":"10.1038\/s41598-021-88630-9","article-title":"The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors","volume":"11","author":"Silvestrini","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2024.100179_bib0028","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555224000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555224000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:46:04Z","timestamp":1726429564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555224000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2472555224000418"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2024.100179","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a sensitive high-throughput enzymatic assay capable of measuring sub-nanomolar inhibitors of SARS-CoV2 Mpro","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2024.100179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100179"}}